Petauri unveils Petauri Advisors

Petauri, a platform supported by private equity specializing in pharmaceutical commercialization services, has introduced Petauri Advisors, led by seasoned professional Steve O’Malley.  

Petauri Advisors emerges as a strategic consultancy in the life sciences domain, emphasizing pricing, compensation, entry, and showcasing value. O’Malley, appointed president, contributes a wealth of expertise from the life sciences sector.  

9 years ago, he established MKO Global Partners, a strategic international life sciences company specializing in advisory services on payer strategy, market entry, and pricing. Prior to that, he introduced more than 50 products in the market access sector for biopharmaceutical companies, including Byetta and Incivek.  

Based in Nashville, the Petauri platform will seek to incorporate firms with proficiency in global market entry, medical affairs, and patient support.  

O’Malley commented, “The biopharmaceutical industry continues to launch innovative and groundbreaking technologies, and demonstrating and communicating the value of these therapies is more important than ever.”  

He went on to add, “We look forward to partnering with clients to launch products with the potential to significantly enhance the lives of patients.” 

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.